Ledger.Open graph →
SEC Form D · Amendment · filed June 17, 2015

Stratos Genomics Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Allan Stephan · Seattle, WAExec · DirectorStephen Rose · Seattle, WADirectorHeiner Dreismann · Seattle, WADirectorHarold Kawaguchi · Seattle, WAExec · DirectorMark Kokoris · Seattle, WAExec · DirectorLee Huntsman · Seattle, WADirectorBob Mcruer · Seattle, WAExec · DirectorSamuel A. Flax · BETHESDA, MDDirectorMalon Wilkus · BETHESDA, MDDirectorTrueBridge Capital GP Partners, L.P · Chapel Hill, NCExec · DirectorAidan Chopra · Boulder, COExec · DirectorJeffrey Smith · Pembroke, MADirectorMel Williams · Chapel Hill, NCExec · DirectorJeffrey Wolf · Durham, NCExec · DirectorTom Wyman · Boulder, COExec · DirectorMark A. Pelletier · NEW YORK, NYExec · DirectorFrank, Iv M. Young · San Francisco, CADirectorJordan N. Richards · San Francisco, CADirectorBob Mcruer · Seattle, WAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗